| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 1363747 | Bioorganic & Medicinal Chemistry Letters | 2009 | 4 Pages | 
Abstract
												A series of piperazine derivatives were designed and synthesised as gp120–CD4 inhibitors. SAR studies led to the discovery of potent inhibitors in a cell based anti viral assay represented by compounds 9 and 28. The rat pharmacokinetic and antiviral profiles of selected compounds are also presented.
Graphical abstractIdentification and SAR of a series of piperazine derivatives as inhibitors of the gp120–CD4 interaction is described.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
												
											Related Topics
												
													Physical Sciences and Engineering
													Chemistry
													Organic Chemistry
												
											Authors
												David H. Williams, Fiona Adam, David R. Fenwick, Juin Fok-Seang, Iain Gardner, Duncan Hay, Rawal Jaiessh, Donald S. Middleton, Charles E. Mowbray, Tanya Parkinson, Manos Perros, Christopher Pickford, Michelle Platts, Amy Randall, Daniel Siddle, 
											